Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate Combined with Corticosteroid for Acute GVHD
NCT04677868Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Dec 2020
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methotrexate in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Peking University People's Hospital. Primary endpoint: Overall Response Rate at 7 days. Status: unknown.
02
Drugs
methotrexate
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT04677868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04677868.